Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.
Identifieur interne : 001240 ( Main/Corpus ); précédent : 001239; suivant : 001241Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.
Auteurs : Sebastian E. Sattui ; Jean W. Liew ; Elizabeth R. Graef ; Ariella Coler-Reilly ; Francis Berenbaum ; Alí Duarte-García ; Carly Harrison ; Maximilian F. Konig ; Peter Korsten ; Michael S. Putman ; Philip C. Robinson ; Emily Sirotich ; Manuel F. Ugarte-Gil ; Kate Webb ; Kristen J. Young ; Alfred H J. Kim ; Jeffrey A. SparksSource :
- Expert review of clinical immunology [ 1744-8409 ] ; 2020.
English descriptors
- KwdEn :
- Antiviral Agents (therapeutic use), Betacoronavirus (drug effects), COVID-19 (MeSH), Communication (MeSH), Coronavirus Infections (drug therapy), Humans (MeSH), Hydroxychloroquine (therapeutic use), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Public Opinion (MeSH), SARS-CoV-2 (MeSH), Treatment Outcome (MeSH).
- MESH :
- chemical , therapeutic use : Antiviral Agents, Hydroxychloroquine.
- drug effects : Betacoronavirus.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- COVID-19, Communication, Humans, Pandemics, Public Opinion, SARS-CoV-2, Treatment Outcome.
Abstract
INTRODUCTION
Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research trials around the world are underway testing a wide array of possible medications. In particular, the off-label use of hydroxychloroquine for COVID-19 prophylaxis and treatment has created many unprecedented challenges for the scientific community and the public.
AREAS COVERED
We critically assessed major events from February - May 2020 that contributed to widespread use of hydroxychloroquine for the treatment and prophylaxis of COVID-19. We aimed to explore how opinions toward hydroxychloroquine may shift from early enthusiasm (based on
EXPERT OPINION
Mindful and rigorous acquisition of data, as well as its interpretation, are essential to an effective pandemic response. The rapid and premature promotion of results has had major implications for global crisis management, even creating distrust among the public. It is crucial for the medical and scientific community to incorporate the lessons learned from this situation.
DOI: 10.1080/1744666X.2020.1792778
PubMed: 32620062
PubMed Central: PMC7594186
Links to Exploration step
pubmed:32620062Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.</title><author><name sortKey="Sattui, Sebastian E" sort="Sattui, Sebastian E" uniqKey="Sattui S" first="Sebastian E" last="Sattui">Sebastian E. Sattui</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine, Hospital for Special Surgery , New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Liew, Jean W" sort="Liew, Jean W" uniqKey="Liew J" first="Jean W" last="Liew">Jean W. Liew</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine, University of Washington , Seattle, WA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Graef, Elizabeth R" sort="Graef, Elizabeth R" uniqKey="Graef E" first="Elizabeth R" last="Graef">Elizabeth R. Graef</name><affiliation><nlm:affiliation>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Coler Reilly, Ariella" sort="Coler Reilly, Ariella" uniqKey="Coler Reilly A" first="Ariella" last="Coler-Reilly">Ariella Coler-Reilly</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , St. Louis, MO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Berenbaum, Francis" sort="Berenbaum, Francis" uniqKey="Berenbaum F" first="Francis" last="Berenbaum">Francis Berenbaum</name><affiliation><nlm:affiliation>Department of Rheumatology, Sorbonne University, INSERM CRSA, AP-HP , Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Duarte Garcia, Ali" sort="Duarte Garcia, Ali" uniqKey="Duarte Garcia A" first="Alí" last="Duarte-García">Alí Duarte-García</name><affiliation><nlm:affiliation>Division of Rheumatology, Mayo Clinic , Rochester, MN, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Harrison, Carly" sort="Harrison, Carly" uniqKey="Harrison C" first="Carly" last="Harrison">Carly Harrison</name><affiliation><nlm:affiliation>LupusChat , New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine , Baltimore, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Korsten, Peter" sort="Korsten, Peter" uniqKey="Korsten P" first="Peter" last="Korsten">Peter Korsten</name><affiliation><nlm:affiliation>Department of Nephrology and Rheumatology, University Medical Center Göttingen , Göttingen, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Putman, Michael S" sort="Putman, Michael S" uniqKey="Putman M" first="Michael S" last="Putman">Michael S. Putman</name><affiliation><nlm:affiliation>Department of Medicine, Northwestern University , Chicago, IL, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Robinson, Philip C" sort="Robinson, Philip C" uniqKey="Robinson P" first="Philip C" last="Robinson">Philip C. Robinson</name><affiliation><nlm:affiliation>University of Queensland Faculty of Medicine , Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Sirotich, Emily" sort="Sirotich, Emily" uniqKey="Sirotich E" first="Emily" last="Sirotich">Emily Sirotich</name><affiliation><nlm:affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, ON, Canada.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Canadian Arthritis Patient Alliance , Toronto, ON, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Ugarte Gil, Manuel F" sort="Ugarte Gil, Manuel F" uniqKey="Ugarte Gil M" first="Manuel F" last="Ugarte-Gil">Manuel F. Ugarte-Gil</name><affiliation><nlm:affiliation>School of Medicine, Universidad Científica Del Sur and Hospital Nacional Guillermo Almenara Irigoyen , EsSalud, Lima, Peru.</nlm:affiliation></affiliation></author><author><name sortKey="Webb, Kate" sort="Webb, Kate" uniqKey="Webb K" first="Kate" last="Webb">Kate Webb</name><affiliation><nlm:affiliation>Department of Paediatric Rheumatology, University of Cape Town , Cape Town, South Africa.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Francis Crick Institute , London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Young, Kristen J" sort="Young, Kristen J" uniqKey="Young K" first="Kristen J" last="Young">Kristen J. Young</name><affiliation><nlm:affiliation>Division of Rheumatic Diseases, UT Southwestern Medical Center , Dallas, TX, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kim, Alfred H J" sort="Kim, Alfred H J" uniqKey="Kim A" first="Alfred H J" last="Kim">Alfred H J. Kim</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , Saint Louis, MO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Sparks, Jeffrey A" sort="Sparks, Jeffrey A" uniqKey="Sparks J" first="Jeffrey A" last="Sparks">Jeffrey A. Sparks</name><affiliation><nlm:affiliation>Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School , Boston, MA, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32620062</idno><idno type="pmid">32620062</idno><idno type="doi">10.1080/1744666X.2020.1792778</idno><idno type="pmc">PMC7594186</idno><idno type="wicri:Area/Main/Corpus">001240</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001240</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.</title><author><name sortKey="Sattui, Sebastian E" sort="Sattui, Sebastian E" uniqKey="Sattui S" first="Sebastian E" last="Sattui">Sebastian E. Sattui</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine, Hospital for Special Surgery , New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Liew, Jean W" sort="Liew, Jean W" uniqKey="Liew J" first="Jean W" last="Liew">Jean W. Liew</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine, University of Washington , Seattle, WA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Graef, Elizabeth R" sort="Graef, Elizabeth R" uniqKey="Graef E" first="Elizabeth R" last="Graef">Elizabeth R. Graef</name><affiliation><nlm:affiliation>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Coler Reilly, Ariella" sort="Coler Reilly, Ariella" uniqKey="Coler Reilly A" first="Ariella" last="Coler-Reilly">Ariella Coler-Reilly</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , St. Louis, MO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Berenbaum, Francis" sort="Berenbaum, Francis" uniqKey="Berenbaum F" first="Francis" last="Berenbaum">Francis Berenbaum</name><affiliation><nlm:affiliation>Department of Rheumatology, Sorbonne University, INSERM CRSA, AP-HP , Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Duarte Garcia, Ali" sort="Duarte Garcia, Ali" uniqKey="Duarte Garcia A" first="Alí" last="Duarte-García">Alí Duarte-García</name><affiliation><nlm:affiliation>Division of Rheumatology, Mayo Clinic , Rochester, MN, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Harrison, Carly" sort="Harrison, Carly" uniqKey="Harrison C" first="Carly" last="Harrison">Carly Harrison</name><affiliation><nlm:affiliation>LupusChat , New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine , Baltimore, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Korsten, Peter" sort="Korsten, Peter" uniqKey="Korsten P" first="Peter" last="Korsten">Peter Korsten</name><affiliation><nlm:affiliation>Department of Nephrology and Rheumatology, University Medical Center Göttingen , Göttingen, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Putman, Michael S" sort="Putman, Michael S" uniqKey="Putman M" first="Michael S" last="Putman">Michael S. Putman</name><affiliation><nlm:affiliation>Department of Medicine, Northwestern University , Chicago, IL, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Robinson, Philip C" sort="Robinson, Philip C" uniqKey="Robinson P" first="Philip C" last="Robinson">Philip C. Robinson</name><affiliation><nlm:affiliation>University of Queensland Faculty of Medicine , Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Sirotich, Emily" sort="Sirotich, Emily" uniqKey="Sirotich E" first="Emily" last="Sirotich">Emily Sirotich</name><affiliation><nlm:affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, ON, Canada.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Canadian Arthritis Patient Alliance , Toronto, ON, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Ugarte Gil, Manuel F" sort="Ugarte Gil, Manuel F" uniqKey="Ugarte Gil M" first="Manuel F" last="Ugarte-Gil">Manuel F. Ugarte-Gil</name><affiliation><nlm:affiliation>School of Medicine, Universidad Científica Del Sur and Hospital Nacional Guillermo Almenara Irigoyen , EsSalud, Lima, Peru.</nlm:affiliation></affiliation></author><author><name sortKey="Webb, Kate" sort="Webb, Kate" uniqKey="Webb K" first="Kate" last="Webb">Kate Webb</name><affiliation><nlm:affiliation>Department of Paediatric Rheumatology, University of Cape Town , Cape Town, South Africa.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Francis Crick Institute , London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Young, Kristen J" sort="Young, Kristen J" uniqKey="Young K" first="Kristen J" last="Young">Kristen J. Young</name><affiliation><nlm:affiliation>Division of Rheumatic Diseases, UT Southwestern Medical Center , Dallas, TX, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kim, Alfred H J" sort="Kim, Alfred H J" uniqKey="Kim A" first="Alfred H J" last="Kim">Alfred H J. Kim</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , Saint Louis, MO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Sparks, Jeffrey A" sort="Sparks, Jeffrey A" uniqKey="Sparks J" first="Jeffrey A" last="Sparks">Jeffrey A. Sparks</name><affiliation><nlm:affiliation>Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School , Boston, MA, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Expert review of clinical immunology</title><idno type="eISSN">1744-8409</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term><term>Betacoronavirus (drug effects)</term><term>COVID-19 (MeSH)</term><term>Communication (MeSH)</term><term>Coronavirus Infections (drug therapy)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (drug therapy)</term><term>Public Opinion (MeSH)</term><term>SARS-CoV-2 (MeSH)</term><term>Treatment Outcome (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>COVID-19</term><term>Communication</term><term>Humans</term><term>Pandemics</term><term>Public Opinion</term><term>SARS-CoV-2</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>INTRODUCTION</b></p><p>Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research trials around the world are underway testing a wide array of possible medications. In particular, the off-label use of hydroxychloroquine for COVID-19 prophylaxis and treatment has created many unprecedented challenges for the scientific community and the public.</p></div><div type="abstract" xml:lang="en"><p><b>AREAS COVERED</b></p><p>We critically assessed major events from February - May 2020 that contributed to widespread use of hydroxychloroquine for the treatment and prophylaxis of COVID-19. We aimed to explore how opinions toward hydroxychloroquine may shift from early enthusiasm (based on </p></div><div type="abstract" xml:lang="en"><p><b>EXPERT OPINION</b></p><p>Mindful and rigorous acquisition of data, as well as its interpretation, are essential to an effective pandemic response. The rapid and premature promotion of results has had major implications for global crisis management, even creating distrust among the public. It is crucial for the medical and scientific community to incorporate the lessons learned from this situation.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32620062</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-8409</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>07</Month></PubDate></JournalIssue><Title>Expert review of clinical immunology</Title><ISOAbbreviation>Expert Rev Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.</ArticleTitle><Pagination><MedlinePgn>659-666</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/1744666X.2020.1792778</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research trials around the world are underway testing a wide array of possible medications. In particular, the off-label use of hydroxychloroquine for COVID-19 prophylaxis and treatment has created many unprecedented challenges for the scientific community and the public.</AbstractText><AbstractText Label="AREAS COVERED">We critically assessed major events from February - May 2020 that contributed to widespread use of hydroxychloroquine for the treatment and prophylaxis of COVID-19. We aimed to explore how opinions toward hydroxychloroquine may shift from early enthusiasm (based on <i>in vitro</i> and preliminary clinical data) to the hope for a miracle cure (through communication and promotion of questionable results) and, finally, to a rise of skepticism as more in-depth analyses are emerging.</AbstractText><AbstractText Label="EXPERT OPINION">Mindful and rigorous acquisition of data, as well as its interpretation, are essential to an effective pandemic response. The rapid and premature promotion of results has had major implications for global crisis management, even creating distrust among the public. It is crucial for the medical and scientific community to incorporate the lessons learned from this situation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sattui</LastName><ForeName>Sebastian E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-3945-6828</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Hospital for Special Surgery , New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liew</LastName><ForeName>Jean W</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0002-8104-2450</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Washington , Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graef</LastName><ForeName>Elizabeth R</ForeName><Initials>ER</Initials><Identifier Source="ORCID">0000-0001-5973-3477</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coler-Reilly</LastName><ForeName>Ariella</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8549-6559</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berenbaum</LastName><ForeName>Francis</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-8252-7815</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, Sorbonne University, INSERM CRSA, AP-HP , Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-García</LastName><ForeName>Alí</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1749-5719</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Mayo Clinic , Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Carly</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6291-587X</Identifier><AffiliationInfo><Affiliation>LupusChat , New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konig</LastName><ForeName>Maximilian F</ForeName><Initials>MF</Initials><Identifier Source="ORCID">0000-0001-5045-5255</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine , Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korsten</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6065-5680</Identifier><AffiliationInfo><Affiliation>Department of Nephrology and Rheumatology, University Medical Center Göttingen , Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putman</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0001-9699-4000</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Northwestern University , Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Philip C</ForeName><Initials>PC</Initials><Identifier Source="ORCID">0000-0002-3156-3418</Identifier><AffiliationInfo><Affiliation>University of Queensland Faculty of Medicine , Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirotich</LastName><ForeName>Emily</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7087-8543</Identifier><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Canadian Arthritis Patient Alliance , Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ugarte-Gil</LastName><ForeName>Manuel F</ForeName><Initials>MF</Initials><Identifier Source="ORCID">0000-0003-1728-1999</Identifier><AffiliationInfo><Affiliation>School of Medicine, Universidad Científica Del Sur and Hospital Nacional Guillermo Almenara Irigoyen , EsSalud, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>Kate</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1087-5946</Identifier><AffiliationInfo><Affiliation>Department of Paediatric Rheumatology, University of Cape Town , Cape Town, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Francis Crick Institute , London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Kristen J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0001-8570-2228</Identifier><AffiliationInfo><Affiliation>Division of Rheumatic Diseases, UT Southwestern Medical Center , Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Alfred H J</ForeName><Initials>AHJ</Initials><Identifier Source="ORCID">0000-0003-4074-0516</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparks</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-5556-4618</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School , Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AR073752</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AR048522</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AR069688</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AR075886</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR072579</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AR066953</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Clin Immunol</MedlineTA><NlmUniqueID>101271248</NlmUniqueID><ISSNLinking>1744-666X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011639" MajorTopicYN="Y">Public Opinion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Hydroxychloroquine</Keyword><Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword><Keyword MajorTopicYN="Y">antimalarials</Keyword><Keyword MajorTopicYN="Y">chloroquine</Keyword><Keyword MajorTopicYN="Y">coronavirus disease 2019</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32620062</ArticleId><ArticleId IdType="doi">10.1080/1744666X.2020.1792778</ArticleId><ArticleId IdType="pmc">PMC7594186</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Rheum Dis. 2020 Jun;79(6):734-736</Citation><ArticleIdList><ArticleId IdType="pubmed">32295786</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 May 14;369:m1849</Citation><ArticleIdList><ArticleId IdType="pubmed">32409561</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2020 Sep;17(9):1425-1433</Citation><ArticleIdList><ArticleId IdType="pubmed">32407884</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation><ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2020 Oct;79(10):1386-1388</Citation><ArticleIdList><ArticleId IdType="pubmed">32381561</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008662</Citation><ArticleIdList><ArticleId IdType="pubmed">32347743</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Sep 1;5(9):1067-1069</Citation><ArticleIdList><ArticleId IdType="pubmed">32936266</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2020 Apr 24;3(4):e208857</Citation><ArticleIdList><ArticleId IdType="pubmed">32330277</ArticleId></ArticleIdList></Reference><Reference><Citation>Med (N Y). 2020 Dec 18;1(1):114-127.e3</Citation><ArticleIdList><ArticleId IdType="pubmed">32838355</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 May 22;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32450107</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Sep 1;5(9):1036-1041</Citation><ArticleIdList><ArticleId IdType="pubmed">32936252</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation><ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2020 May 1;368(6490):476-477</Citation><ArticleIdList><ArticleId IdType="pubmed">32327600</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation><ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation><ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugs. 2017 Dec;77(18):1935-1966</Citation><ArticleIdList><ArticleId IdType="pubmed">29143192</ArticleId></ArticleIdList></Reference><Reference><Citation>Travel Med Infect Dis. 2020 Mar - Apr;34:101663</Citation><ArticleIdList><ArticleId IdType="pubmed">32289548</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation><ArticleIdList><ArticleId IdType="pubmed">32492293</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 May 19;323(19):1897-1898</Citation><ArticleIdList><ArticleId IdType="pubmed">32208486</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 May 14;369:m1844</Citation><ArticleIdList><ArticleId IdType="pubmed">32409486</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Rheumatol. 2020 May;2(5):e250-e253</Citation><ArticleIdList><ArticleId IdType="pubmed">32309814</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Jun 23;323(24):2493-2502</Citation><ArticleIdList><ArticleId IdType="pubmed">32392282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2020 Jun 16;172(12):819-821</Citation><ArticleIdList><ArticleId IdType="pubmed">32227189</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2020 Jun 2;172(11):754-755</Citation><ArticleIdList><ArticleId IdType="pubmed">32232419</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Jun 25;382(26):2582</Citation><ArticleIdList><ArticleId IdType="pubmed">32501665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2020 Jun;79(6):837-839</Citation><ArticleIdList><ArticleId IdType="pubmed">32332072</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105923</Citation><ArticleIdList><ArticleId IdType="pubmed">32070753</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2411-2418</Citation><ArticleIdList><ArticleId IdType="pubmed">32379955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2020 Jun;79(6):e61</Citation><ArticleIdList><ArticleId IdType="pubmed">32295787</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 Mar 23;368:m1166</Citation><ArticleIdList><ArticleId IdType="pubmed">32205321</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Jun 13;395(10240):1820</Citation><ArticleIdList><ArticleId IdType="pubmed">32511943</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001240 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001240 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32620062
|texte= Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32620062" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |